Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model

Cancer Immunology, Immunotherapy : CII
Jamile R SilvaMariana O Diniz

Abstract

The presence of IL-10, produced either by tumor cells or immunosuppressive cells, is frequently associated with a poor prognosis for cancer progression. It may also negatively impact anticancer treatments, such as immunotherapies, that otherwise would promote the activation of cytotoxic T cells capable of detecting and destroying malignant cells. In the present study, we evaluated a new adjuvant approach for anticancer immunotherapy using a plasmid vector encoding a soluble form of the IL-10 receptor (pIL-10R). pIL-10R was coadministered to mice with a DNA vaccine encoding the type 16 human papillomavirus (HPV-16) E7 oncoprotein genetically fused with glycoprotein D of herpes simplex virus (HSV) (pgDE7h). Immunization regimens based on the coadministration of pIL-10R and pgDE7h enhanced the antitumor immunity elicited in mice injected with TC-1 cells, which express HPV-16 oncoproteins. The administration of the DNA vaccines by in vivo electroporation further enhanced the anticancer effects of the vaccines, leading to the activation of tumor-infiltrating polyfunctional E7-specific cytotoxic CD8+ T cells and control of the expansion of immunosuppressive cells. In addition, the combination of immunotherapy and pIL-10R allowed the ...Continue Reading

References

Oct 21, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephen C De RosaMario Roederer
Sep 22, 2006·Viral Immunology·Juan Manuel Alcocer-GonzálezVicente Madrid-Marina
May 31, 2007·The Journal of Experimental Medicine·Melissa L PrecopioRichard A Koup
Sep 18, 2008·Cancer Investigation·Victor H Bermudez-MoralesVicente Madrid-Marina
Apr 1, 2009·The Journal of Experimental Medicine·Gabrielle A RizzutoAlan N Houghton
Nov 9, 2010·Advances in Immunology·Roberto A Maldonado, Ulrich H von Andrian
Sep 16, 2011·Cancer Immunology, Immunotherapy : CII·Cailin Moira WilkeWeiping Zou
Nov 1, 2012·Human Vaccines & Immunotherapeutics·Anita Gothelf, Julie Gehl
Jun 27, 2013·Oncoimmunology·Kavitha YaddanapudiJohn W Eaton
Dec 4, 2013·Cold Spring Harbor Perspectives in Biology·Toine ten BroekeWillem Stoorvogel
Mar 22, 2014·Biomedical Reports·Yan WangOu Li
Jan 18, 2015·Cellular Immunology·Guoying NiXiaosong Liu
May 20, 2015·Human Vaccines & Immunotherapeutics·Si-Hyeong LeeJeong-Im Sin
Jan 10, 2016·BMC Genomics·Sophia BornsteinShannon McWeeney
Oct 13, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Li LiXin-Yan Xu
Apr 4, 2017·Cytokine & Growth Factor Reviews·Fernanda Costa Brandão BertiKaren Brajão de Oliveira

❮ Previous
Next ❯

Citations

Mar 12, 2020·Human Vaccines & Immunotherapeutics·Guoying NiXiaosong Liu
Aug 10, 2021·Oncoimmunology·Jamile Ramos da SilvaLuís Carlos de Souza Ferreira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.